Veeva Systems Inc. reported strong Q2 revenue growth of 18%, surpassing both company guidance and analyst expectations. The company is actively reducing its share count through a $2 billion buyback program, which supports earnings per share growth by offsetting stock-based compensation. With $1.4 billion remaining in the buyback plan, a strong balance sheet holding $1.8 billion in cash and $5.4 billion in short-term investments, and minimal debt, Veeva is well-positioned for downside protection. Trading at a forward PEG ratio of 0.77 and significantly undervalued compared to its sector, the stock has been upgraded from Hold to Buy.
Alnylam Pharmaceuticals saw its stock drop sharply after it lowered its 2026 sales guidance by about $200 million due to slower demand for its TTR products. Despite a strong biotech sector, Alnylam's shares fell by $81.14 per share, losing about 25% ...
Malibu Boats reported a strong fourth quarter with net sales up 42.7% to $295.5 million and adjusted EBITDA rising 72.7% to $33.9 million, beating earnings estimates with $0.92 per share versus $0.75 expected. The company benefits from organic growth...
Science Applications International Corporation (SAIC) is set to report its Q3 2026 earnings on August 31, with analysts expecting an EPS of $2.31 and revenue of $1.76 billion, both down from last year. Despite the decline, the company offers a quarte...
BYD Company Limited reported strong Q2 2026 results with earnings per share of $0.14, beating analyst estimates of $0.11. The company leads the global electric vehicle market by delivery volume and outperforms competitors like Tesla in profit margins...
SentinelOne reported Q2 fiscal 2027 revenue of about $292 million, a 21% increase year-over-year, beating estimates. Bernstein kept its Outperform rating and raised the price target from $19 to $21. Despite strong earnings and a 10% non-GAAP operatin...
